InsidersTradesSigma
Follow the 이노진 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 이노진 has logged 1 reports. Market capitalisation: €13.2bn. The latest transaction was reported on 8 April 2026 (Sale). Among the most active insiders: ANTONIUS RACHMAT SOELISTYO. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
이노진 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for disease treatment.